Chiropractic & Manual Therapies is a premier open-access journal published by BMC, dedicated to advancing the fields of Chiropractic, Complementary and Alternative Medicine, and Physical Therapy. Since its inception in 2011, the journal has established its reputation within the academic community, evidenced by its Q1 ranking in Chiropractics and Complementary and Alternative Medicine, and Q2 in Physical Therapy, Sports Therapy, and Rehabilitation as of 2023. With an impressive Scopus ranking placing it in the top 5% for Chiropractics and maintaining a strong presence in the complementary medicine sector, Chiropractic & Manual Therapies serves as a critical platform for researchers, practitioners, and students seeking to disseminate innovative findings and practical advancements in manual therapies. Located in the United Kingdom, the journal not only promotes accessible research but also contributes to the ongoing discourse in healthcare practices, ensuring valuable insights are shared widely among professionals and the academic community.

The Cochrane Database of Systematic Reviews is a premier journal published by WILEY, focusing on the critical appraisal and synthesis of high-quality research in health care. With its dedication to evidence-based practice, this journal serves as a cornerstone for researchers, healthcare professionals, and students alike, offering pivotal insights through rigorous systematic reviews. Although it is not an open-access publication, its influence in guiding clinical decision-making and policy formulation is profound, underscored by its contributions to the advancement of healthcare knowledge. Based in the United States at 111 River St, Hoboken, NJ, the Cochrane Database has established itself as essential reading for those seeking to stay at the forefront of systematic reviews and meta-analyses in the medical field, ensuring that users are well-equipped with the evidence necessary for informed practice.

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

Expert Review of Pharmacoeconomics & Outcomes Research is a leading journal published by TAYLOR & FRANCIS LTD, focusing on the critical intersection of pharmacoeconomics and healthcare outcomes. Established in 2001, the journal has been a key resource for researchers and professionals in the fields of health policy, medicine, and pharmacology, consistently ranked in the top quartile of these categories for its influential insights. With an ISSN of 1473-7167 and an E-ISSN of 1744-8379, it delivers cutting-edge research that informs healthcare decisions and policy frameworks. The journal's rigorous peer-review process ensures the publication of high-quality, impactful articles that address contemporary challenges and advancements in pharmacoeconomic evaluations. As of 2023, it boasts a commendable ranking of #106 in Health Policy and #124 in Pharmacology, affirming its relevance and contribution to the field. Despite being a subscription-based journal, the strength of its content makes it an invaluable tool for researchers and practitioners aiming to enhance patient outcomes and optimize resource allocation in healthcare systems.

Cost Effectiveness and Resource Allocation is a premier open-access journal published by BMC, dedicated to advancing the field of health policy and economics. Since its inception in 2003, the journal has provided a platform for researchers, policymakers, and healthcare professionals to disseminate crucial findings and insights relevant to cost-effectiveness analyses and resource allocation strategies. With an increasing impact factor and ranking within the Q2 category of health policy journals, it ranks #138 out of 310 in Scopus, placing it in the 55th percentile among its peers. The journal aims to facilitate knowledge exchange that can transform health policy and improve healthcare delivery through rigorous research, evaluation, and dialogue. Open access since its establishment, it ensures that critical findings are available to a global audience, thereby enhancing the impact and reach of its published works.

The British Journal of Surgery, published by OXFORD UNIV PRESS, stands as a preeminent periodical in the field of surgery, as evidenced by its impressive impact factor and esteemed ranking of #7 out of 551 in the Scopus category of Medicine - Surgery, placing it in the 98th percentile. Since its inception in 1913, the journal has dedicated itself to disseminating cutting-edge research, innovative surgical techniques, and comprehensive meta-analyses, thereby shaping the future of surgical practice and education. With a robust commitment to academic rigor, it has consistently maintained a prestigious position in the Q1 category of surgery as of 2023, affirming its relevance in the modern medical landscape. The journal provides essential access to healthcare professionals, researchers, and students passionate about advancing surgical knowledge and improving patient outcomes. Operated from its headquarters in Oxford, United Kingdom, the British Journal of Surgery is pivotal for anyone looking to stay at the forefront of surgical advancements.

Welcome to the Journal of Patient-Reported Outcomes, a premier platform dedicated to advancing the field of health informatics and health information management. Published by SPRINGERNATURE since 2017, this Open Access journal allows researchers and practitioners globally to disseminate vital research findings, ensuring that insights into patient-reported outcomes reach a wider audience without barriers. With its current standing in the Q2 quartile for both Health Informatics and Health Information Management in 2023, it is positioned as a significant contributor to the healthcare research community, ranking 76th out of 138 in Medicine and 34th out of 59 in Health Professions. The journal aims to publish high-quality, peer-reviewed articles that explore innovative methodologies, enhance clinical decision-making, and ultimately improve patient care outcomes. By offering a platform for interdisciplinary collaboration, the Journal of Patient-Reported Outcomes fosters a deeper understanding of patients' perspectives in healthcare, making it an essential resource for researchers, professionals, and students alike.

The Journal of Integrated Care, published by EMERALD GROUP PUBLISHING LTD, serves as a vital platform for scholars and practitioners engaged in the multidisciplinary fields of health, public administration, and sociology. With the ISSN 1476-9018 and E-ISSN 2042-8685, this journal has established a significant presence since its inception in 1996, and continues to contribute to the advancement of integrated care practices. The journal is ranked in the Q3 quartile for Health (social science) and Public Administration, and holds a Q2 ranking in Sociology and Political Science, reflecting its influence and relevance in these fields. With a commitment to disseminating high-quality research, the Journal of Integrated Care aims to bridge gaps among various disciplines, offering insightful analysis and innovative solutions to contemporary challenges in integrated care systems. Although Open Access options are not available, the journal's articles enrich the knowledge base of professionals, researchers, and students alike, facilitating meaningful dialogue and collaboration as it converges toward its goal of improved holistic care by 2024. For further details, visit the journal's address in the United Kingdom at Floor 5, Northspring, 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND.

ADVANCES IN THERAPY is a prestigious peer-reviewed journal published by SPRINGER, specializing in the diverse fields of medicine and pharmacology. Established in 1984, this influential journal has become an essential resource for researchers and professionals, boasting a commendable impact factor and categorically ranking within the Q1 quartile in both Medicine (Miscellaneous) and Medical Pharmacology as of 2023. With an impressive Scopus ranking at #52 out of 272 in the realm of medical pharmacology, it places itself in the top 81st percentile, underscoring its importance in advancing therapeutic knowledge and practices. Although the journal is not open access, it provides invaluable insights and the latest research findings in therapies that significantly impact patient care, making it a vital reference for clinicians, academicians, and students alike.

Applied Health Economics and Health Policy, published by Springer International Publishing AG, stands as a premier academic journal dedicated to the intersection of economic theory and health policy. With a strong focus on the practical application of economic principles to health issues, this journal addresses crucial topics such as healthcare financing, resource allocation, and economic evaluation of health interventions. Its impressive rankings—in the top quartile for both Health Policy and Medicine, as well as a notable second quartile in Economics—illustrate its significant impact within the fields of health economics and policy research. The journal is aimed at researchers, policymakers, and students who seek to explore innovative solutions to contemporary health challenges. Established in 2002 with ongoing publications through 2024, the journal features open access options that enhance accessibility and engagement with its extensive body of research articles, ensuring that vital insights are available to a global audience.